Neurological complications after COVID-19: A narrative review.

Autor: Molaverdi G; Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran., Kamal Z; Institute of Biochemistry and Biophysics, University of Tehran, Tehran, Iran., Safavi M; Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran., Shafiee A; Student Research Committee, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.; Clinical Research Development Unit, Alborz University of Medical Sciences, Karaj, Iran., Mozhgani SH; Department of Microbiology and Virology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran.; Non-Communicable Disease Research Center, Alborz University of Medical Sciences, Karaj, Iran., Ghobadi MZ; Independent Researcher, Tehran, Iran., Goudarzvand M; Non-Communicable Disease Research Center, Alborz University of Medical Sciences, Karaj, Iran.; Physiology - Pharmacology- Medical Physics Department, Faculty of Medicine, Alborz University of Medical Sciences.

Publikováno v: ENeurologicalSci [eNeurologicalSci] 2023 Nov 15; Vol. 33, pp. 100485. Date of Electronic Publication: 2023 Nov 15 (Print Publication: 2023).

Dysregulation of miR-193a serves as a potential contributor to MS pathogenesis via affecting RhoA and Rock1.

Autor: Saeidi N; DNA Laboratory, Analytical Laboratories, Hamilton, New Zealand., Goudarzvand H; National Standard Organization of Iran, Tehran, Iran., Mohammadi H; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Mardi A; Department of Immunology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran., Ghoreishizadeh S; Department of Immunology, School of Medicine, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Shomali N; Immunology Research Center, Tabriz University of Medical Sciences, Tabriz, Iran., Goudarzvand M; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran; Department of Physiology and Pharmacology, Faculty of Medicine, Alborz University of Medical Sciences, Karaj, Iran. Electronic address: m.godarzvand@abzums.ac.ir.

Publikováno v: Multiple sclerosis and related disorders [Mult Scler Relat Disord] 2023 Jan; Vol. 69, pp. 104468. Date of Electronic Publication: 2022 Dec 13.

Pycnogenol ameliorates motor function and gene expressions of NF-ƙB and Nrf2 in a 6-hydroxydopamine-induced experimental model of Parkinson's disease in male NMRI mice.

Autor: Jafari F; Department of Biology, Faculty of Life Sciences, Islamic Azad University, North Tehran Branch, Tehran, Iran., Goudarzvand M; Department of Physiology and Pharmacology, School of Medicine, Alborz University of Medical Sciences, Karaj, Iran. m.godarzvand@abzums.ac.ir.; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran. m.godarzvand@abzums.ac.ir., Hajikhani R; Department of Biology, Faculty of Biological Sciences, Islamic Azad University, North Tehran Branch, Tehran, Iran., Qorbani M; Non-Communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran., Solati J; Department of Biology, Faculty of Basic Sciences, Islamic Azad University, Karaj Branch, Karaj, Iran.

Publikováno v: Naunyn-Schmiedeberg's archives of pharmacology [Naunyn Schmiedebergs Arch Pharmacol] 2022 Mar; Vol. 395 (3), pp. 305-313. Date of Electronic Publication: 2022 Jan 13.

Metabolic-driven analytics of traumatic brain injury and neuroprotection by ethyl pyruvate.

Autor: Golovachev, Nikita¹ (AUTHOR), Siebold, Lorraine¹ (AUTHOR), Sutton, Richard L.² (AUTHOR), Ghavim, Sima² (AUTHOR), Harris, Neil G.² (AUTHOR), Bartnik-Olson, Brenda³ (AUTHOR) bbartnik@llu.edu

Publikováno v: Journal of Neuroinflammation. 11/14/2024, Vol. 21 Issue 1, p1-21. 21p.

Anti-Inflammatory Effect of KW-2449 on Autoimmune Encephalomyelitis: An Experimental Study on Mice.

Autor: Ahmadabad HN; Department of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran., Abbaspour A; Department of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran., Panahi Y; Department of Pathobiology and Laboratory Sciences, Faculty of Medicine, North Khorasan University of Medical Sciences, Bojnurd, Iran., Tahmasebi S; Research Center for Applied Plant Sciences, Arak Branch, Islamic Azad University, Arak, Iran., Hossein-Khannazer N; Gastroenterology and Liver Diseases Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran., Afraei S; Department of Cell and Molecular Biology, University of Tehran, Tehran, Iran., Miladi H; Department of Pathology, Imam Khomeini Hospital Affiliated to Social Security Organization, Arak, Iran., Goudarzvand M; Department of Physiology and Pharmacology, School of medicine, Alborz University of Medical Sciences, Karaj, Iran., Kamali AN; CinnaGen Medical Biotechnology Research Center, Alborz University of Medical Sciences, Karaj, Iran., Bagheri Y; Clinical Research Development Unit (CRDU), 5 azar Hospital, Golestan University of Medical Sciences, Gorgan, Iran., Yazdani R; Research Centre for Immunodeficiencies, Children's Medical Centre, Tehran University of Medical Sciences, Tehran, Iran., Di Fiore MM; Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Via Vivaldi 43, 81100Caserta, Italy., Azizi G; Non-communicable Diseases Research Center, Alborz University of Medical Sciences, Karaj, Iran.

Publikováno v: Endocrine, metabolic & immune disorders drug targets [Endocr Metab Immune Disord Drug Targets] 2021; Vol. 21 (9), pp. 1590-1597.